IMMX
Price
$3.07
Change
-$0.00 (-0.00%)
Updated
Mar 28, 6:59 PM EST
62 days until earnings call
UBX
Price
$1.64
Change
+$0.01 (+0.61%)
Updated
Mar 28, 6:59 PM EST
Ad is loading...

Analysis and predictions IMMX vs UBX

Header iconIMMX vs UBX Comparison
Open Charts IMMX vs UBXBanner chart's image
Immix Biopharma
Price$3.07
Change-$0.00 (-0.00%)
Volume$56.92K
CapitalizationN/A
Unity Biotechnology
Price$1.64
Change+$0.01 (+0.61%)
Volume$49.16K
CapitalizationN/A
View a ticker or compare two or three
IMMX vs UBX Comparison Chart

Loading...

IMMXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
UBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
IMMX vs. UBX commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMMX is a Hold and UBX is a StrongBuy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (IMMX: $3.07 vs. UBX: $1.64)
Brand notoriety: IMMX and UBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMMX: 18% vs. UBX: 49%
Market capitalization -- IMMX: $78.14M vs. UBX: $27.53M
IMMX [@Biotechnology] is valued at $78.14M. UBX’s [@Biotechnology] market capitalization is $27.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $576.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.64B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMMX’s FA Score shows that 0 FA rating(s) are green whileUBX’s FA Score has 0 green FA rating(s).

  • IMMX’s FA Score: 0 green, 5 red.
  • UBX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMMX and UBX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMMX’s TA Score shows that 5 TA indicator(s) are bullish while UBX’s TA Score has 4 bullish TA indicator(s).

  • IMMX’s TA Score: 5 bullish, 2 bearish.
  • UBX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IMMX is a better buy in the short-term than UBX.

Price Growth

IMMX (@Biotechnology) experienced а +0.99% price change this week, while UBX (@Biotechnology) price change was +7.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.78%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +88.40%.

Reported Earning Dates

IMMX is expected to report earnings on May 29, 2024.

UBX is expected to report earnings on May 09, 2023.

Industries' Descriptions

@Biotechnology (+4.78% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for IMMX with price predictions.
OPEN
A.I.dvisor published
a Summary for UBX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IMMX($78.1M) has a higher market cap than UBX($27.5M). UBX YTD gains are higher at: -15.026 vs. IMMX (-55.636). IMMX has higher annual earnings (EBITDA): -14.21M vs. UBX (-47.73M). UBX has more cash in the bank: 45.9M vs. IMMX (19.6M). IMMX has less debt than UBX: IMMX (50K) vs UBX (24.4M). IMMX (0) and UBX (0) have equivalent revenues.
IMMXUBXIMMX / UBX
Capitalization78.1M27.5M284%
EBITDA-14.21M-47.73M30%
Gain YTD-55.636-15.026370%
P/E RatioN/AN/A-
Revenue00-
Total Cash19.6M45.9M43%
Total Debt50K24.4M0%
FUNDAMENTALS RATINGS
UBX: Fundamental Ratings
UBX
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMMXUBX
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 15 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
IMMXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
UBXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FSBW34.711.10
+3.27%
FS Bancorp
POR41.990.31
+0.74%
Portland General Electric Company
ALX216.660.75
+0.35%
Alexander's
KDP30.670.06
+0.20%
Keurig Dr Pepper
EKSO1.36-0.06
-4.23%
Ekso Bionics Holdings

IMMX and

Correlation & Price change

A.I.dvisor tells us that IMMX and AVRO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IMMX and AVRO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMMX
1D Price
Change %
IMMX100%
+0.33%
AVRO - IMMX
30%
Poorly correlated
+1.59%
ORMP - IMMX
27%
Poorly correlated
+2.82%
PDSB - IMMX
25%
Poorly correlated
+3.26%
PRTC - IMMX
24%
Poorly correlated
-0.03%
UBX - IMMX
23%
Poorly correlated
+1.23%
More